Last reviewed · How we verify
Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU (Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU) — Seoul National University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU TARGET | Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU | Seoul National University Hospital | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU CI watch — RSS
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU CI watch — Atom
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU CI watch — JSON
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU alone — RSS
Cite this brief
Drug Landscape (2026). Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU — Competitive Intelligence Brief. https://druglandscape.com/ci/freeze-dried-concentrated-human-antithrombin-500-iu. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab